Clinical Trial Update: QUILT-3.070:Pancreatic Cancer Vaccine: Subjects With Pancreatic Cancer Who Have Progressed on or After Standard-of-care Therapy [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 pancreatic cancer vaccine QUILT-3.070 from ImmunityBio was terminated with results posted in May 2024.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• QUILT-3.070 (QUILT-3.070)

Snippet

Sponsor: ImmunityBio, Inc. | Conditions: Pancreatic Cancer | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2024-05-22